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Abstract
Background: Miliary pulmonary nodules are commonly caused by various infections and cancers.
We sought to identify the relative frequencies of various aetiologies and the clinical and
radiographic predictors of miliary tuberculosis (TB) in patients with miliary pulmonary nodules.
Methods:  We performed a retrospective cohort study of patients who presented with
micronodules occupying more than two-thirds of the lung volume, based on computed tomography
(CT) of the chest, between November 2001 and April 2007, in a tertiary referral hospital in South
Korea.
Results: We analyzed 76 patients with miliary pulmonary nodules. Their median age was 52 years
and 38 (50%) were males; 18 patients (24%) had a previous or current malignancy and five (7%) had
a history of TB. The most common diagnoses of miliary nodules were miliary TB (41 patients, 54%)
and miliary metastasis of malignancies (20 patients, 26%). Multivariate analysis revealed that age ≤30
years, HIV infection, corticosteroid use, bronchogenic spread of lesions, and ground-glass opacities
occupying >25% of total lung volume increased the probability of miliary TB. However, a history of
malignancy decreased the probability of miliary TB.
Conclusion: Miliary TB accounted for approximately half of all causes of miliary pulmonary
nodules. Young age, an immune-compromised state, and several clinical and radiographic
characteristics increased the probability of miliary TB.
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Background
Miliary pulmonary nodules are commonly caused by var-
ious infections and cancers. In fact, a heterogeneous
groups of conditions comprising more than 80 entities
may result in miliary nodules [1]. Among them, miliary
tuberculosis (TB) is one of the most frequent aetiologies
in areas with a high prevalence of TB [2]. However,
approximately two-thirds of all miliary TB cases are acid-
fast bacilli (AFB) smear-negative, and even transbronchial
biopsy frequently fails to reveal AFB or caseating granulo-
mas [3-5]. In such cases, the remaining options for the
rapid diagnosis of miliary TB include invasive procedures
such as open lung biopsy or empirical anti-TB treatment,
depending on the probability of miliary TB based on clin-
ical and radiographic findings. Nonetheless, no recent
report has examined the role of clinical characteristics in
the differential diagnosis of miliary pulmonary nodules.
Moreover, the clinical role of radiographic findings in dif-
ferentiating between miliary TB and other aetiologies of
miliary pulmonary nodules has not been established,
although differential diagnosis based on the distribution
of miliary nodules in high-resolution computed tomogra-
phy has been studied [2,6-8].
We examined the relative frequencies of various aetiolo-
gies of miliary pulmonary nodules and sought to identify
clinical and radiographic predictors of miliary TB in a ter-
tiary referral hospital in South Korea, where the incidence
of active TB was reported to be about 96/100,000 persons
in 2005 [9].
Methods
Study subjects
We included all adult patients (≥18 years of age) who pre-
sented with miliary nodules, based on computed tomog-
raphy (CT) of the chest, between November 2001 and
April 2007. Patients were selected from Seoul National
University Hospital, a tertiary referral hospital in South
Korea. Miliary nodules were defined as micronodules (<7
mm in diameter [10]), regardless of solid or non-solid
nature, occupying more than two-thirds of the lung vol-
ume on a conventional chest CT or high-resolution chest
CT. We excluded patients whose physician had not fully
evaluated the cause of the miliary nodules, patients who
defaulted before obtaining a final diagnosis, and patients
with concurrent discrete macronodules (>7 mm in diam-
eter). However, patients with concurrent consolidations
were included.
The study protocol was approved by the institutional
review board of Seoul National University Hospital.
Study design
We performed a retrospective cohort study to examine the
relative frequencies of aetiologies of miliary pulmonary
nodules and to assess clinical and radiographic predictors
of miliary TB. Enrolled patients were classified into two
groups, miliary TB and miliary nodules due to other
causes, according to the final diagnosis of their miliary
pulmonary nodules. To reveal predictors of miliary TB,
clinical and radiographic characteristics were analyzed
between the groups.
Review of clinical findings and laboratory tests
We retrospectively reviewed the demographic and clinical
characteristics, including age, gender, body mass index
(BMI), and symptoms, of the selected patients. In addi-
tion, we checked for the presence of previous TB, malig-
nancy, diabetes mellitus, immunosuppressive drug
therapy, solid organ transplantation, connective tissue
disease, chronic kidney disease, chronic liver disease, HIV
infection, and alcoholism. We also reviewed the results of
laboratory tests, including complete blood cell counts,
blood chemistry, and C-reactive protein levels. The results
of histopathological examinations and microbiological
studies, including acid-fast staining, mycobacterial cul-
tures, and fungal cultures, were also reviewed.
Radiographic evaluations
Chest CT scans performed at the time of diagnosis were
reviewed by two board-certified radiologists, by consen-
sus. They were blinded to patient clinical data and had not
participated in the case selection.
Characteristics and distribution of miliary nodules
Miliary nodules were assessed for size, margin, profusion,
and dominant distribution. Considering previous reports
that miliary nodules from cancer usually consist of micro-
nodules of variable size or relatively large micronodules
(4–7 mm in diameter) [1,11], we described the size of the
miliary nodules as 'homogeneous' when the sizes of all
micronodules were confined to 0–4 mm. The profusion of
nodules was estimated by counting all nodules in two
contiguous squares of 4 cm2 on three levels: just above the
aortic arch, the right upper lobar bronchus, and the lower
portion of the left atrium [7]. The dominant distribution
of miliary nodules within secondary pulmonary lobules
was described as centrilobular, perilymphatic, or random
[1,2,6,11].
Definition of bronchogenic spread and pre-existing 
tuberculosis (TB) sequelae
Poorly defined centrilobular nodules, branching linear
lesions, tree-in-bud appearance, and bronchial wall thick-
ening were classified as indicating the bronchogenic
spread of lesions [7]. Patients with fibrotic bands, small
calcified nodules, or bronchiectasis observable in the
upper lobes were regarded as having pre-existing TB
sequelae [12,13]. Mediastinal lymph nodes >1 cm in
short-axis diameter were considered positive signs of lym-BMC Infectious Diseases 2008, 8:160 http://www.biomedcentral.com/1471-2334/8/160
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phadenopathy. Additionally, we assessed the extent of
accompanying ground-glass opacities, consolidations,
and pleural effusions.
Diagnostic criteria
Miliary TB was confirmed if any of the following was met:
(1) positive staining for AFB, the growth of Mycobacterium
tuberculosis, or positive PCR for M. tuberculosis DNA in spu-
tum, bronchial lavage fluid, pleural fluid, or tissue; (2) the
presence of caseating granulomas in lung tissue and clini-
cal and radiographic improvement with anti-TB medica-
tions; or (3) definite clinical and radiographic
improvement with empirical anti-TB medications. Miliary
metastasis of malignancies was identified when any of the
following was met: (1) cytological/histological examina-
tion of miliary nodules showing malignant cells; or (2)
concurrent changes in the size and number of miliary
nodules relative to the size of measurable primary malig-
nant lesions. For example, concurrent decreases in the
sizes of both primary lesions and miliary nodules in a
patient receiving anti-cancer chemotherapy would be
such a case. Pneumoconiosis was diagnosed based on
occupational history and compatible clinical and radio-
graphic findings. Disseminated fungal diseases were
defined using bacteriological or pathological analyses of
miliary nodules. Hypersensitivity pneumonitis was diag-
nosed by environmental or occupational history and
improvement with environmental control or corticoster-
oid treatment.
Statistical analyses
To identify factors for differentiating between TB-associated
miliary nodules and miliary nodules due to other causes, we
performed univariate analyses using the χ2 test or Fisher's
exact test for categorical variables, and using t tests for contin-
uous variables. To determine predictors of miliary TB, we
performed binary logistic regression analysis with significant
(P < 0.05) variables from the univariate analysis. Co-linearity
was eliminated by stepwise selection (entry, p  = 0.05;
removal, p = 0.1). Because some predictors were likely to be
found only within the miliary TB group, we used the penal-
ized likelihood ratio test to determine significance. For the
same reason, odds ratios and 95% confidence intervals were
estimated using the penalized maximum likelihood and
profile penalized likelihood confidence intervals, respec-
tively. Statistical significance was determined at P < 0.05. All
analyses were performed using SPSS (version 12.0, SPSS Inc.,
Chicago, IL, USA) or SAS (version 8.2, SAS Institute Inc.,
Cary, NC, USA).
Results
Demographic and clinical characteristics of patients with 
miliary pulmonary nodules
A total of 182 patients diagnosed with and treated for mil-
iary pulmonary nodules during the study period were ini-
tially screened for inclusion in this study. Of these, 102
patients were excluded because of concurrent discrete
macronodules (>7 mm in diameter), mass lesions sugges-
tive of primary lung cancer, or cavitations suggestive of
pulmonary TB. Indeed, the diagnoses of the 102 patients
excluded from further analysis were metastatic cancer (65
patients), miliary TB (29 patients), and pneumoconiosis
(8 patients). An additional four patients were excluded
because they defaulted before obtaining a final diagnosis.
Finally, data for 76 patients were included and analyzed.
Their median age was 52 years and 38 (50%) of them were
males; 18 patients (24%) had a previous or current malig-
nancy and five (7%) had a history of TB (Table 1).
Aetiologies of miliary pulmonary nodules
Among the 76 patients, miliary TB accounted for 54% of
the miliary pulmonary nodules (41 patients). Of these, 31
patients (76%) were diagnosed by positive staining for
AFB, the growth of Mycobacterium tuberculosis, or positive
PCR for M. tuberculosis DNA in sputum, bronchial lavage
fluid, pleural fluid, cerebrospinal fluid, or tissue. In five
patients (12%), diagnoses were made by the presence of
caseating granulomas in lung tissue and clinical and radi-
ographic improvement with anti-TB medications. The
other five patients (12%) were diagnosed based on defi-
nite clinical and radiographic improvement with empiri-
cal anti-TB medications. Miliary metastasis of
malignancies accounted for 26% of the miliary pulmo-
nary nodules (20 patients). Of these, direct histological
Table 1: Demographic and clinical characteristics of 76 patients 
with miliary nodules.
Age (yr), median (range) 52 (21–86)
Male 38 (50%)
Body mass index (kg/m2), mean ± SD 21.8 ± 3.0*
Smoking history
Current smoker 12/74 (16%)
Ex-smoker 3/74 (4%)
Median pack-years (range) 30 (3–50)
Body temperature > 37.8°C 21/61 (34%)
Leukocytosis (>10,000/mm3) 11/72 (15%)
C-reactive protein (mg/dL), mean ± SD 4.9 ± 5.6†
Previous or current malignancy 18 (24%)
Solid organ cancer 12
Hematologic malignancy 6
History of previous TB 5 (7%)
Comorbidities
Diabetes mellitus 2 (3%)
HIV infection 7 (9%)
Corticosteroid use‡ 9 (12%)
Connective tissue disease 6 (8%)
Solid organ transplantation 2 (3%)
Chronic kidney disease§ 2 (3%)
* Result of 61 subjects
† Result of 55 subjects
‡ Prednisolone equivalent ≥5 mg/d for >3 wk.
§Glomerular filtration rate <60 mL/min/1.73 m2 for 3 or more 
months.BMC Infectious Diseases 2008, 8:160 http://www.biomedcentral.com/1471-2334/8/160
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confirmation of miliary pulmonary nodules via lung
biopsy was achieved in one patient. Three patients were
diagnosed with disseminated candidiasis, all with an
underlying hematologic malignancy (Table 2).
Clinical and radiological findings associated with miliary 
TB
With univariate analysis, we found that age ≤30 years, HIV
infection, corticosteroid use, connective tissue disease,
low BMI, body temperature >37.7°C, homogeneous nod-
ule size, high profusion, bronchogenic spread of lesions,
and ground-glass opacities occupying >25% of total lung
volume were associated with miliary TB. However, a his-
tory of solid organ malignancy decreased the probability
of miliary TB (Tables 3, 4). Subsequent multivariate anal-
ysis supported the association between miliary TB and age
≤30 years, HIV infection, corticosteroid use, bronchogenic
spread of lesions, and ground-glass opacities occupying
>25% of total lung volume, as well as the association
between miliary nodules of non-miliary TB and a history
of malignancy (Table 5).
Discussion
Although the prevalence of active pulmonary TB in South
Korea decreased from 5.1% in 1965 to 0.33% in 2005
[14], this study showed that miliary TB still accounted for
approximately half of all cases of miliary pulmonary nod-
ules in the patients examined. The proportion of miliary
TB among miliary pulmonary nodules in the present
study was higher than that in a previous study by Lee et al.
(22.5%) in a South Korean population [2]. This discrep-
ancy is probably the result of differences in study design.
In the previous study, patients without biopsy-proven
diagnoses were not included [2], which might have
excluded a considerable portion of miliary TB patients
who may have been identified by bacteriological studies.
Our study indicated that age ≤30 years, HIV infection, and
corticosteroid use were strong independent predictors of
miliary TB (Table 5). Although miliary TB is relatively rare
among young adults without HIV infection in developed
nations [15], about one-quarter of the non-HIV-infected
patients with miliary TB in this study were ≤30 years of
age. This difference may be attributable to the relatively
high incidence of TB in South Korea, where the annual
incidence of active TB has been reported to be about 96/
100,000 persons per year [9].
Other risk factors for miliary TB, including diabetes melli-
tus [3-5], a history of prior TB [4,5], chronic kidney dis-
ease [3-5], and hematologic malignancies [16], failed to
show an association in our study population (Table 3).
These differences may also be attributable to study design.
All of the subjects in the present study had miliary pulmo-
nary nodules, and clinical characteristics were subse-
quently compared between miliary TB patients and
patients with other miliary pulmonary nodules. However,
previous studies compared clinical characteristics between
miliary TB patients and healthy controls without TB [3-5].
Certain clinical features are more common in miliary TB
patients than in the general population, but these factors
may have less significance in the clinical setting of miliary
pulmonary nodules of various aetiologies.
A history of hematologic or solid malignancy (OR, 0.1;
95% CI, 0.0–0.7) was a strong negative predictor of mil-
iary TB in our study (Table 5). Although hematologic and
solid organ malignancy is a known risk factor for the reac-
tivation of TB [16-22], the presence of a history of malig-
nancy decreased the probability of miliary TB in our
study. The miliary nodules found in 13 of 18 patients
(72%) with underlying malignancies represented metas-
tases of those underlying malignancies.
Among radiographic findings, this study revealed that the
bronchogenic spread of lesions and ground-glass opaci-
ties occupying >25% of total lung volume were associated
with miliary TB. This confirmed a previous observation
that these parameters are frequently found in miliary TB
[7,23]. However, a random distribution of miliary nod-
ules on high-resolution computed tomography scans,
which is a well-known characteristic of miliary TB [1,2,6-
8,23], was not identified as a predictor in this study. This
may reflect the fact that all malignant miliary nodules
showed a random distribution in our study. Although a
random distribution can be helpful in differentiating
between miliary TB and diffuse panbronchiolitis [2,11] or
sarcoidosis [1,2,6,7,11], its usefulness in diagnosis may be
limited in clinical situations where the majority of miliary
nodules are caused by miliary TB or malignant metastasis.
To correctly appreciate these results, the limitations of this
study should be considered. First, this study was per-
formed in South Korea, where the annual incidence of
Table 2: Etiologies of 76 patients with miliary nodules.
Tuberculosis 41 (54%)
Disseminated candidiasis 3 (4%)
Malignancy 20 (26%)
Lung cancer* 7
Breast cancer 5
Thyroid cancer 2
Others† 6
Pneumocconiosis 6 (8%)
Sarcoidosis 4 (5%)
Hypersensitivity pneumonitis 2 (3%)
*Six of them had adenocarcinoma of non-bronchioloalveolar 
carcinoma histology and the other had bronchioloalveolar carcinoma.
†Advanced gastric cancer (1 patient), prostate cancer (1 patient), non-
Hodgkin's lymphoma (1 patient), pancreas cancer (1 patient), parotid 
gland adenoid cystic carcinoma (1 patient), thymic carcinoma (1 
patient)BMC Infectious Diseases 2008, 8:160 http://www.biomedcentral.com/1471-2334/8/160
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active TB has been reported to be about 96/100,000 per-
sons per year [9]. Any generalization of the results to
patients in areas with higher or lower TB rates should be
made with caution. Second, we did not include patients
who had miliary nodules but no CT scan, and we excluded
patients with discrete lung masses. Thus, the results
should be applied cautiously and should not be applied
to cases with miliary nodules of clinically apparent causes.
For example, a case of miliary nodules with a concurrent
spiculated mass highly suggestive of lung cancer would
not be applicable to the results of this study. Third, the
confidence intervals of the odds ratios for some variables
were wide, as a result of the small numbers of patients in
some categories. Future studies prospectively recruiting a
Table 3: Univariate analysis of clinical characteristics between patients with miliary tuberculosis and other diseases
TB (n = 41) Other diseases (n = 35) P value
Age ≤30 10 (24%) 1 (3%) .008
Male 22 (54%) 16 (46%) .490
Body mass index (kg/m2), mean 20.6 ± 3.2 (n = 32) 23.1 ± 2.2 (n = 29) .001
Ever-smoking 5/40 (13%) 10/34 (29%) .197
Body temperature > 37.7°C 19/39 (49%) 2/22 (9%) .002
Leukocytosis 6/40 (15%) 5/32 (16%) 1.000
C-reactive protein (mg/dL) 5.9 ± 4.8 (n = 35) 3.1 ± 6.5 (n = 20) .070
Presence of classic risk factor for miliary TB*
History of malignancy 2 (5%) 16 (46%) <.001
Solid organ cancer 0 12 (34%) <.001
Hematologic malignancy 2 (5%) 4 (11%) .405
History of previous TB 4 (10%) 1 (3%) .366
Diabetes mellitus 2 (5%) 0 .496
HIV infection 7 (17%) 0 .013
Corticosteroid use† 9 (22%) 0 .003
Connective tissue disease 6 (15%) 0 .028
Solid organ transplantation 2 (5%) 0 .496
Chronic kidney disease‡ 2 (5%) 0 .496
*There could be more than one risk factor.
†Prednisolone equivalent ≥5 mg/d for >3 wk.
‡Glomerular filtration rate <60 mL/min/1.73 m2 for 3 or more months.
Table 4: Univariate analysis of radiographic characteristics between patients with miliary tuberculosis and other diseases
TB (n = 41) Other diseases (n = 35) P value
Homogeneous nodule size* 30 (73%) 17 (49%) .028
Dominant distribution
Random 37 (90%) 30 (86%) .794
Centrilobular 2 (5%) 2 (6%)†
Perilymphatic 2 (5%) 3 (9%)‡
Profusion (N/cm2)
Upper 5.2 ± 2.7 3.2 ± 2.6 .002
Middle 5.2 ± 2.6 3.1 ± 2.5 .001
Lower 4.6 ± 2.5 2.5 ± 2.5 .001
Overall 5.0 ± 2.4 2.9 ± 2.3 <.001
Sharp margin 30 (75%) 20 (57%) .102
Bronchogenic spread of lesion 23 (56%) 5 (14%) <.001
Ground-glass opacity extent
None 20 (49%) 24 (69%) .082
0–25% 11 (27%) 10 (29%) .866
25–100% 10 (24%) 1 (3%) .008
Preexisting TB lesion 5 (12%) 5 (14%) 1.000
Pleural effusion 15 (37%) 10 (29%) .459
Mediastinal lymphadenopathy 16 (39%) 20 (57%) .115
Consolidation 17 (42%) 16 (46%) .709
*Size of all micronodules confined to 0–4 mm
†Peumocconiosis (n = 1), hypersensitivity pneumonia (n = 1)
‡Sarcoidosis (n = 2), pneumoconiosis (n = 1)BMC Infectious Diseases 2008, 8:160 http://www.biomedcentral.com/1471-2334/8/160
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larger number of patients should be performed to confirm
the results of this study.
Conclusion
In conclusion, although the prevalence of TB has mark-
edly decreased in South Korea, miliary TB still accounts
for about half of all causes of miliary pulmonary nodules.
To avoid delayed anti-TB treatment, miliary TB should be
seriously considered in patients with the factors identified
in this study: ≤30 years of age, HIV infection, corticoster-
oid use, absence of a history of malignancy, bronchogenic
spread of lesions, or ground-glass opacities occupying
>25% of total lung volume in chest CT scans.
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